These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15551208)

  • 21. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
    Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
    Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
    Minke JM; Siger L; Karaca K; Austgen L; Gordy P; Bowen R; Renshaw RW; Loosmore S; Audonnet JC; Nordgren B
    Arch Virol Suppl; 2004; (18):221-30. PubMed ID: 15119777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.
    Li N; Zhang YN; Deng CL; Shi PY; Yuan ZM; Zhang B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus).
    Langevin SA; Arroyo J; Monath TP; Komar N
    Am J Trop Med Hyg; 2003 Jul; 69(1):78-80. PubMed ID: 12932102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
    Alonso-Padilla J; de Oya NJ; Blázquez AB; Escribano-Romero E; Escribano JM; Saiz JC
    Vaccine; 2011 Feb; 29(9):1830-5. PubMed ID: 21211580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equine Immunoglobulin and Equine Neutralizing F(ab')₂ Protect Mice from West Nile Virus Infection.
    Cui J; Zhao Y; Wang H; Qiu B; Cao Z; Li Q; Zhang Y; Yan F; Jin H; Wang T; Sun W; Feng N; Gao Y; Sun J; Wang Y; Perlman S; Zhao J; Yang S; Xia X
    Viruses; 2016 Dec; 8(12):. PubMed ID: 27999340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A live attenuated West Nile virus strain as a potential veterinary vaccine.
    Lustig S; Olshevsky U; Ben-Nathan D; Lachmi BE; Malkinson M; Kobiler D; Halevy M
    Viral Immunol; 2000; 13(4):401-10. PubMed ID: 11192286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.
    Venter M; van Vuren PJ; Mentoor J; Paweska J; Williams J
    Vaccine; 2013 Aug; 31(37):3856-62. PubMed ID: 23820079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
    Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
    Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
    Verstrepen BE; Oostermeijer H; Fagrouch Z; van Heteren M; Niphuis H; Haaksma T; Kondova I; Bogers WM; de Filette M; Sanders N; Stertman L; Magnusson S; Lőrincz O; Lisziewicz J; Barzon L; Palù G; Diamond MS; Chabierski S; Ulbert S; Verschoor EJ
    PLoS One; 2014; 9(11):e112568. PubMed ID: 25392925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY; Silengo SJ; Whiteman MC; Kinney RM
    J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
    Van Hoeven N; Joshi SW; Nana GI; Bosco-Lauth A; Fox C; Bowen RA; Clements DE; Martyak T; Parks DE; Baldwin S; Reed SG; Coler RN
    PLoS One; 2016; 11(2):e0149610. PubMed ID: 26901122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model.
    Tesh RB; Arroyo J; Travassos Da Rosa AP; Guzman H; Xiao SY; Monath TP
    Emerg Infect Dis; 2002 Dec; 8(12):1392-7. PubMed ID: 12498653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever vector live-virus vaccines: West Nile virus vaccine development.
    Arroyo J; Miller CA; Catalan J; Monath TP
    Trends Mol Med; 2001 Aug; 7(8):350-4. PubMed ID: 11516995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.
    Iyer AV; Pahar B; Boudreaux MJ; Wakamatsu N; Roy AF; Chouljenko VN; Baghian A; Apetrei C; Marx PA; Kousoulas KG
    Vaccine; 2009 Feb; 27(6):893-903. PubMed ID: 19070640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant envelope protein vaccine against West Nile virus.
    Ledizet M; Kar K; Foellmer HG; Wang T; Bushmich SL; Anderson JF; Fikrig E; Koski RA
    Vaccine; 2005 Jun; 23(30):3915-24. PubMed ID: 15917113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
    Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.